xMAP® Technology by Luminex

Manufacturer Luminex  |  Available Worldwide
Bead-based multiplexing of up to 500 analytes per sample.


xMAP® Technology by Luminex product image
xMAP® Technology
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Luminex’s xMAP® Technology combines advanced fluidics, optics, and digital signal processing with proprietary microsphere technology to deliver multiplexed assay capabilities. Featuring a flexible, open-architecture design, xMAP Technology can be configured to perform a wide variety of protein or nucleic acid assays quickly, cost-effectively and accurately.

Open-architecture xMAP Technology enables multiplexing of biological tests (assays), reducing time, labor, and costs over traditional methods such as ELISA, western blotting, PCR, and traditional arrays. Systems using xMAP Technology perform discrete assays on the surface of color coded beads known as microspheres, which are then read in a compact analyzer. Using multiple lasers or LEDs and high-speed digital-signal processors, the analyzer reads multiplex assay results by reporting the reactions occurring on each individual microsphere.

 

Features & Benefits:

  • Multiplexing reduces costs and labor
  • Generates more data with less sample
  • Delivers faster, more reproducible results than solid, planar arrays
  • Focused, flexible multiplexing of one to 500 analytes meets the needs of a wide variety of applications — protein expression profiling, focused gene expression profiling, autoimmune disease, genetic disease, molecular infectious disease, and HLA testing
  • Open architecture platform allows leading partner companies to provide compatible kits and software for the xMAP Technology platform

Product Overview

xMAP® Technology by Luminex product image

xMAP® Technology

Manufacturer Luminex  |  Available Worldwide

Be the first to review this product